Medicina
Departamento
José María
Miró Meda
Publicaciones en las que colabora con José María Miró Meda (133)
2024
-
Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 1989-2000
-
Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort
Open Forum Infectious Diseases, Vol. 11, Núm. 3
-
Infective endocarditis in HIV-infected patients. Analysis of a national cohort
Infectious Diseases
2023
-
Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry
PloS one, Vol. 18, Núm. 9, pp. e0290998
-
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012) (Infectious Diseases and Therapy, (2023), 12, 4, (1083-1101), 10.1007/s40121-023-00763-8)
Infectious Diseases and Therapy
-
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci
International Journal of Antimicrobial Agents, Vol. 62, Núm. 3
-
Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)
Infectious Diseases and Therapy, Vol. 12, Núm. 4, pp. 1083-1101
-
Heart transplantation as salvage treatment of intractable infective endocarditis
Infectious Diseases, Vol. 55, Núm. 5, pp. 370-374
-
Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 77, Núm. 9, pp. 1273-1281
-
Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data from the GAMES Series (2008-2021)
Open Forum Infectious Diseases, Vol. 10, Núm. 8
-
Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections
Frontiers in Medicine, Vol. 10
2022
-
Infective endocarditis in children and adolescents: a different profile with clinical implications
Pediatric Research, Vol. 92, Núm. 5, pp. 1400-1406
-
Multivalvular Endocarditis: A Rare Condition with Poor Prognosis
Journal of Clinical Medicine, Vol. 11, Núm. 16
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2021
-
Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock
Clinical Infectious Diseases, Vol. 73, Núm. 5, pp. 765-774
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 9, pp. 1517-1525
-
Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis
Clinical Microbiology and Infection